Familial Cerebral Cavernous Malformations: A Case Report

Jesús Octavio Tafoya Hernández *

Diagnostic Imaging Resident, Hospital General "Dr. Miguel Silva," Morelia, Michoacán, México.

Rodolfo Alberto Del Corral Vázquez

Diagnostic Imaging Resident, Hospital General "Dr. Miguel Silva," Morelia, Michoacán, México.

Leidi Johana Rodríguez Sotto

Diagnostic Imaging Resident, Hospital General "Dr. Miguel Silva," Morelia, Michoacán, México.

Julián Andrés Bucheli Buesaco

Diagnostic Imaging Resident, Hospital General "Dr. Miguel Silva," Morelia, Michoacán, México.

Joaquín Núñez Gomez

Radiology Department, Hospital General "Dr. Miguel Silva," Morelia, Michoacán, México.

Agustín Parra Macias

Radiology Department, Hospital General "Dr. Miguel Silva," Morelia, Michoacán, México.

*Author to whom correspondence should be addressed.


Aims: Describe the main imaging findings of familial cerebral cavernous malformations.

Presentation of Case: This is the clinical case of a 68-year-old woman with a history of type 2 diabetes mellitus and long-standing systemic arterial hypertension. She presents to the neurology outpatient clinic reporting dizziness, temporal-spatial disorientation, episodes of amnesia, and chronic insomnia. Based on the clinical presentation, a diagnosis of cognitive impairment, likely of vascular origin. The MRI reveals multiple supratentorial and intraxial lesions with heterogeneous components, exhibiting a hypointense ring on T1 and T2-weighted sequences with images demonstrate a "blooming" effect on the T2*/GRE sequence, characteristic of cerebral cavernomas, displaying a "popcorn" appearance.

Discussion: In the presented case, a patient with multiple cerebral cavernomas showing classic features on MRI was discussed. Clinical manifestations commonly involving seizures, hemorrhage, and focal neurological deficits. Genetic factors play a role, with familial cases following an autosomal dominant inheritance pattern. Imaging studies, particularly MRI with susceptibility-weighted imaging, aid in diagnosis, revealing characteristic "popcorn" appearance lesions. Other differential diagnoses for cerebral hemorrhages should be considered, including vascular brain malformations and conditions like cerebral amyloid angiopathy and hypertensive encephalopathy. Management involves a multidisciplinary approach, with surgical resection being the gold standard for symptomatic cases.

Conclusion: Cerebral cavernous malformations (CCM) present varied symptoms, diagnosed through MRI showcasing characteristic appearances. Accurate determination of familial or sporadic origin is crucial for tailored treatment, involving medical therapy, surgical resection, or radiosurgery. Multidisciplinary collaboration among specialties ensures personalized management for patients with CCM.

Keywords: Cavernoma, familial cerebral cavernous malformations, hemorrhage, magnetic resonance imaging, cerebral vascular anomalies

How to Cite

Hernández, J. O. T., Vázquez , R. A. D. C., Sotto , L. J. R., Buesaco , J. A. B., Gomez , J. N., & Macias , A. P. (2024). Familial Cerebral Cavernous Malformations: A Case Report. Asian Journal of Medicine and Health, 22(6), 89–94. https://doi.org/10.9734/ajmah/2024/v22i61024


Download data is not yet available.


Coban A, Gurses C, Bilgic B, Sencer S, Karasu A, Bebek N, Baykan B, Hepgul KT, Gokyigit A. Sporadic multiple cerebral cavernomatosis: Report of a case and review of literature. The Neurologist. 2008; 14(1):46–49.

Mohammadi J. Imaging features of cerebral vascular malformations. J Med Imaging Radiat Sci. 2013;44(2):71 –8.

Perrini P, Lanzino G. The association of venous developmental anomalies and cavernous malformations: pathophysiological, diagnostic, and surgical considerations. Neurosurg Focus. 2006;21(1):1–4.

Mondejar R, Lucas M. Diagnóstico molecular de cavernomatosis cerebral. Neurologia. Español. 2017;32(8):540–5.

Awad IA, Polster SP. Cavernous angiomas: Deconstructing a neurosurgical disease. J Neurosurg. 2019; 131(1):1–13.

Baranoski JF, Kalani MYS, Przybylowski CJ, Zabramski JM. Cerebral cavernous malformations: Review of the genetic and protein–protein interactions resulting in disease pathogenesis. Front Surg. 2016;3.

Flemming KD, Smith E, Marchuk D, et al. Familial Cerebral Cavernous Malformations. 2003 Feb 24 [Updated 2023 Jul 27]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews®. Seattle (WA): University of Washington, Seattle;1993-2024.

Labauge P, Denier C, Bergametti F, Tournier-Lasserve E. Genetics of cavernous angiomas. Lancet Neurol. 2007; 6(3):237–44.

Choquet H, Pawlikowska L, Lawton MT, Kim H. Genetics of cerebral cavernous malformations: current status and future prospects. J Neurosurg Sci. 2015;59(3) :211-20.

De Souza, JM, Domingues, RC, Cruz, LC, et al. Susceptibility-weighted imaging for the evaluation of patients with familial cerebral cavernous malformations: a comparison with T2-weighted fast spin-echo and gradient-echo sequences. Am J Neuroradiol. 2008;29:154–8. DOI: http://dx.doi. org/10.3174/ajnr.A0748

Zhang J, Croft J, Le A. Familial CCM Genes Might Not Be Main Drivers for Pathogenesis of Sporadic CCMs-Genetic Similarity between Cancers and Vascular Malformations. J Pers Med. 2023; 13(4):673.

DOI: 10.3390/jpm13040673.

Mespreuve M, Vanhoenacker F, Lemmerling M. Familial Multiple Cavernous Malformation Syndrome: MR Features in This Uncommon but Silent Threat. J Belg Soc Radiol. 2016 ;100(1):51.

DOI: 10.5334/jbr-btr.938.

Santos AN, Rauschenbach L, Saban D, Chen B, Lenkeit A, Gull HH, Rieß C, Deuschl C, Schmidt B, Jabbarli R, Wrede KH, Zhu Y, Frank B, Sure U, Dammann P. Medication intake and hemorrhage risk in patients with familial cerebral cavernous malformations. J Neurosurg. 2022:1-7.

DOI: 10.3171/2022.

Stapleton CJ, Barker FG II. Cranial cavernous malformations: Natural history and treatment. Stroke. 2018;49(4):1029–35.